Skip to content
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

Program in Health Economics and Outcomes Research Methodologies (PHEnOM)

The Program in Health Economics and Outcomes Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Service in the School of Public Health at the University of Washington, Seattle. The program aims to facilitate intellectual activities within the departments in the fields of health economics, econometrics and methodology development in outcomes research and to engage researchers in allied fields around the city of Seattle. Key competencies of PHEnOM affiliates include health econometrics, health policy evaluation, applications in health capital, aging and disability, organization of health care, simulations methods, and comparative and cost-effectiveness analysis.

The PHEnOM Seminar is also offered as a 1 credit course to interested students. The course, HEOR 598, is a great opportunity for students to receive credit for attending and participating in our weekly research seminars. Please contact us if you have any questions on the details of the course.

Subscribe to the phenom-info email list.

PHEnOM Co-Directors

Douglas Barthold, PhD

Dr. Douglas Barthold joined the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute faculty in 2018, after completing a postdoctoral fellowship at the Schaeffer Center for Health Policy and Economics at the University of Southern California. He received his Ph.D. in Economics from McGill University in 2015, with a specialization in empirical health economics. Dr. Barthold is broadly interested in the relationships between health policies, healthcare utilization, and health outcomes and inequalities. His current research examines the intersection between health policies, chronic disease management, and cognition, from mid-life to end-of-life. This includes the role of health policies in the management of mid-life risk factors for Alzheimer’s disease and related dementias (ADRD), as well as the value of care for conditions that influence healthy aging. Read more:

Jing Li, PhD

Dr. Jing Li is an Assistant Professor of Health Economics at the CHOICE Institute with research interests in the economic, social and behavioral factors affecting individual decision-making in health and healthcare, for both providers and patients (especially older adults with cognitive impairment), and the impact of policies that leverage these factors to improve patient outcomes and healthcare market efficiency. Methodologically, she is interested in innovatively applying advanced experimental and econometric methods to addressing understudied questions in health economics and policy. Dr. Li was a faculty at Cornell University prior to joining UW. She received a PhD in Health Economics and MA in Economics from University of California, Berkeley, and an MA in International Comparative Education from Stanford University. Read more:

Past Co-Directors: Jerome Dugan, PhD, Norma Coe, PhD, Anirban Basu, PhD

PHEnOM Seminar Series

PHEnOM hosts a weekly seminar series during the academic year. All students, faculty and other researchers interested in this area are welcome to attend the seminar series.  The seminar is offered in-person and by Zoom on Wednesday 3 – 4:30pm. In-Person Location: Department of Pharmacy Conference Room, H-371. For the Zoom link, please contact the seminar organizers or subscribe to our list-serv. To present or attend the PHEnOM seminar series, contact Douglas Barthold at or Jing Li at

2024 Spring Quarter Seminar Schedule

Dates Speaker Title
Mar 27 First Wednesday – no seminar
Apr 3 Jorge Rivero Type fixed effects and rational addiction: A GMM framework for latent type heterogeneity
Apr 10 Erfan Loghmani Investigating the Impact of Advertising on Smoking Cessation: The Important Role of DTC Prescription Drug Advertising
Apr 17 Felipe Montano-Campos Bridging Data Gaps and Predicting Future Trends: A Local Imputation and Prediction Algorithm for Continuous Biomarker Monitoring in Chronic Myeloid Leukemia
Apr 24 Anirban Basu Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies
May 1 Lauren Nicholas How Do Surrogates Make Treatment Decisions for Patients with Dementia?  An Experimental Survey Study
May 8 ISPOR – no seminar
May 15 Esha Dwibedi Changes in lifetime spending and health-adjusted life-expectancy in the United States, 1996 to 2016
May 22 Riley League Administrative Burden and Consolidation in Health Care: Evidence from Medicare Contractor Transitions
May 29 Last Wednesday – no seminar

Seminar Archives


Jan 10
Logan Trenaman
Ordering choice sets by complexity in a discrete choice experiment can reduce self-reported attribute non-attendance

Jan 17
Shiven Bhardwaj and Jennifer Bacci
Exploring Association Between Receipt of Pediatric Vaccine at Pharmacy and Timeliness of Well-Child Visits

Jan 24
Lucy Hong and Cheng Chen
Evaluating E-Cigarette Sales Restrictions: Insights into Consumption and Substitution Behavior.

Jan 31
Graeme Peterson
The Geography of Health Disparities

Feb 14
Ziyue Xu
Fracking Boom and Respiratory Health: Evidence from Texas

Feb 21
Maitreyi Sahu
Linking drugs to diagnoses: generating a probabilistic map using Market Scan claims data

Feb 28
Zhang Zhang
The Evaluation of Telehealth Provider Payment Parity on Health Service Utilization among Working-age Population with Chronic Conditions in the US

Jan 18
Mark Meiselbach
Minimum Wage Laws and the Design and Provision of Employer-Sponsored Health Insurance

Jan 25
Hoa Vu
The Effects of Residential Segregation on Infant Health

Feb 1
Valentyn Litvin
Tried and True or New and Improved? Using Clinical Guidelines to Balance Innovation and Expertise

Feb 8
Vikesh Amin
Does Schooling Improve Cognitive Abilities at Older Ages: Causal Evidence from Nonparametric Bounds

Feb 15
Jens Grueger
Market Access and Implications of IRA beyond the U.S.

Feb 22
Hawre Jalal
Dynamics of Opioid and Drug Overdoses in the United States and Opportunities for Interventions

Mar 29
Yunfei Li
Advancing infectious disease modeling for public health decision-making

Apr 5
Melissa Mugambi
Developing attributes and levels for a discrete choice experiment to design pharmacy-based HIV prevention services for pregnant women in Western Kenya

Apr 12
Alton Russell
Informing targeted public health measures with data-driven decision modeling

Apr 19
Dan Zeltzer
The Impact of Increased Access to Telemedicine

Apr 26
Jakub Hlavka
The Economics of Disease-Modifying Therapies in Alzheimer’s Disease

May 17
Melissa Knox
Using Electronic Health Records for Policy Evaluation: The Case of Seattle’s Sweetened Beverage Tax

May 24
Ramanan Laxminarayan (hosted by the Economics Department – Savery Hall 130)
On the Value of Disease Surveillance

Oct 4
Xiaoxue Li
The Effect of State EITC Expansions on Alcohol Purchase: Evidence from Nielsen Consumer Panel Data

Oct 11
Parker Rogers
Regulating the Innovators: Approval Costs and Innovation in Medical Technologies

Oct 18
Kandice Kapinos
Long-Acting Reversible Contraceptives and Adolescent Childbearing: Changes in Clinical Guidelines for Intrauterine Devices

Nov 1
Monisha Sharma
Maximum price threshold for long-acting PrEP in sub-Saharan Africa: a modeling analysis

Nov 8
Antonio Moreno Llamas
Differences in self-rated health status, mental health symptoms, and physical functioning comparing Spanish and US health surveys in individuals with chronic diseases

Nov 15
Hyunju Kim
Biomarkers of Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction

Nov 29
Stipica Mudrazija
Current and Future Costs of Caregiving for Older Adults with Alzheimer’s Disease and Related Dementias

Jan 5
Brandyn Churchill
Adult Vaccine Recommendations: Morbidity and Firm Response

Jan 12
Kyu Eun Lee
Forecasting the Burden of Disease Using Simulation Models

Jan 19
Ferdous Sardar
Adoption and Impact of Mobile Health Services: Experimental Evidence from Bangladesh

Jan 26
Noah Hammarlund
Isolating the Drivers of Racial Disparities in Emergency Cardiac Surgery

Feb 2
Chuck Phelps
Advances in GRACE methodology

Feb 9
Carol Levin
Economic evaluation of complex interventions.  Overview, Application and Results from the Strengthening Economic Evaluation of Multisectoral Strategies for Nutrition (SEEMS-Nutrition)

Feb 16
Karen Smith
Quasi-experimental versus observational methods for modeling the outcomes of blood pressure changes

Feb 23
Sherri Rose
Fairness and Generalizing to Target Populations

Mar 9
Enrique Saldarriaga
Using sociodemographic and political data to identify COVID-19 vaccine hesitancy predictors

Apr 6
Kevin Lu
Trends and effects of health insurance plans with chronic conditions

Apr 13
Vilsa Curto
Price, Steering, and Utilization Effects of Vertical Integration between Physicians and Hospitals

Apr 20
Emily Ann Cuddy
Rules vs. Discretion: Treatment of Mental Illness in US Adolescents

Apr 27
Anirban Basu
Race in Algorithms

May 11
Boshen Jiao
Economic Value of Expanding First-Line Treatment Choices

Jun 1
Susan E. Bronskill
Health system use and outcomes in persons living with dementia: what can we learn from population-based data?

Sep 28
Kayleigh Barnes
The Pink Tax: Gender Differences in Consumption Spending

Oct 5
Min Hee Kim
Mechanistic pathways linking neighborhood disadvantage with cardiovascular risk factors: Quasi-experimental evidence from a refugee dispersal policy in Denmark

Oct 12
Jing Li
Dementia and Long-run Trajectories in Household Finances

Oct 19
Jiani Yu
Physician Management Companies and Prices, Utilization, and Clinical Outcomes: Evidence from Neonatology

Nov 2
Vincent Pohl
Evaluation of the Medicare Care Choices Model

Nov 9
Augustine Denteh
Who Increases Emergency Department Use? New Insights from the Oregon Health Insurance Experiment

Nov 16
Dan Zeltzer         T
he Impact of Increased Access to Telemedicine

Nov 30
Donghoon Lee
Do for-profit hospitals cream-skim patients? Evidence from inpatient psychiatric care in California

Dec 7
Manasvini Singh
How Power Shapes Behavior: Evidence from Physicians

Jan 6
Yingying Dong
Regression Discontinuity Designs with a Continuous Treatment

Jan 13
Jill Furzer
Diagnostic errors in child mental health: Assessing treatment selection and its long-term consequences

Jan 20
Kelly Anderson
White and Brown Bagging of Physician-Administered Drugs in Medicare: Uptake and Implications for Spending and Patient Access

Jan 27
Elaine Liu
Malleability in Alcohol Consumption: Evidence from Migrants

Feb 3
Alice Ellyson
Sexual violence reporting among college athletes: A discrete choice experiment

Feb 10
Sindana Ilango
The effect of local-level policies on air pollution and health in aging populations

Feb 17
Noah Hammarlund
Decomposing racial disparities in prostate cancer treatment

Feb 24
Rebecca Myerson
Finding the Missing Enrollees: The Impact of Personalized Assistance on Health Insurance Uptake

Mar 3
Stacie Dusetzina
Drug Prices and Access to Medications in Medicare Part D

Mar 10
Bianca Frogner
Entry and exit patterns of health care workers during COVID

Mar 31
Samin Jalali
Heterogeneities in Medicaid Effect: Evidence from Oregon Health Insurance Experiment

Apr 7
Monica Aswani
Measurement Error in the Hospital Readmission Reduction Program

Apr 14
Maura Coughlin
Regional and Demographic Heterogeneity in Consideration in Medicare Part D Plan Choice

Apr 21
Stacie Dusetzina
Drug prices and access to medications in Medicare Part D

Apr 28
Peter Hull
The mortality effects of Medicare advantage plans

May 5
Pedro H.C. Sant’Anna
Difference-in-Differences with multiple time periods

May 12
Jonathan Roth
When Is Parallel Trends Sensitive to Functional Form?

May 19
Noah Simon
Effect-size estimation in high dimensional problems

May 26
Edward Kennedy
Robust causal inference with continuous instruments using the local instrumental variable curve

Sep 29
Aaron Kesselheim and William Feldman
Estimating Rebates in Studies of Medicare Drug Pricing

Oct 13
Melissa Knox
Employment Quality and Health Behaviors during COVID-19

Oct 20
Chad Meyerhoefer
Do Elections Make You Sick? Evidence from First-Time Voters

Oct 27
Erin Trish
Redesigning Medicare Part D

Nov 3
Nathaniel Hendrix
Radiologist Preferences for Implementation of Artificial Intelligence-Based Clinical Decision Support and Risk Prediction

Nov 10
Job Market Talk

Nov 17
Meng Li
Competition, drug characteristics, and rebate of branded prescription drugs

Dec 8
Neil Jay Sehgal
Gender differences in salary among internal medicine physicians at five academic medical centers in California

Jan 15, 2020
Greg Guzauskas
Cost-effectiveness of Oral Semaglutide for Type 2 Diabetes: An ICER Microsimulation Model

Jan 22, 2020
Betty Bekemeier
A Uniform Chart of Accounts for Public Health: Finally measuring Public Health investments in the United States

Jan 29, 2020
Anirban Basu
Finding Value: Pending Reforms to Prescription Drug Pricing in the United States

Feb 5, 2020
Lauren Strand
Recreational cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2018

Feb 12, 2020
Alice Ellyson
The effect of PDMPs on opioid prescribing behavior among the elderly

Feb 19, 2020
Emily Williams
Implementing care for opioid use disorders in VA primary care: an operationally partnered effort

Feb 26, 2020
Wei-Jhih Wang
Mimicking Clinical Trials Using Real-World Data – A Novel Method and Applications

Mar 4, 2020
Charles Phelps
Advances in Cost-Effectiveness-Analysis Methods

Apr 1, 2020
Lauren Olsho
Reducing Early Childhood Obesity: Impacts of Efforts to Improve Nutrition and Physical Activity in Los Angeles County, California

Apr 8, 2020
Kate Johnson
Cost-Effectiveness of Case Detection Strategies for the Early Detection of COPD

Apr 22, 2020
Shuxian Chen
Market dynamics with respect to more generic drug competition

Apr 29, 2020
Tracy Mroz
Variation in Employment of Therapy Assistants in Skilled Nursing Facilities Based on Organizational Factors

May 6, 2020
Jessica Jones-Smith and Kelsey Kinderknecht
Was the Healthy Hunger Free Kids Act of 2010 successful in improving diet quality for lower-income children? Evidence from the National Health and Nutrition Examination Survey

May 13, 2020
Diana Poehler
Developing a Multi-Criteria Decision Analysis ( MCDA) in the Context of Critical Limb Ischemia: Challenges and Solutions

Oct 7, 2020
Erin Morgan
State Earned Income Tax Credits: Anti-Poverty Policy and Health

Oct 14, 2020
Luis Diego Granera
Primary healthcare access and its effects on standard of living: evidence from Costa Rica

Oct 21, 2020
Mark Fendrick
Turning the COVID-19 Crisis into Opportunity: Using Value-Based Insurance Design to Increase Use of High-value Care and Eliminate Low Value Services

Oct 28, 2020
Kosali Simon
Effects of State COVID-19 Closure Policy on NON-COVID-19 Health Care Utilization

Nov 4, 2020
Marcia Weaver
Health spending efficiency in the United States: Cause-Specific Health Spending per Disability-Adjusted Life-Year Averted from 1996 to 2016

Nov 18, 2020
Jinyi Zhu
Evaluating bias and variance across different validation methods of simulation models

Dec 2, 2020
Melissa Knox
Does early childhood access to health insurance affect schooling in Mexico?

Dec 9, 2020
Beth Devine & Enrique Saldarriaga
Assessment of Payers’ Preferences for Real World Evidence: A Discrete Choice Experiment

Jan 9, 2019
Noah Hammarlund
Diagnosing Clinical Treatment Disparities with Machine Learning-Based Decomposition

Jan 16, 2019
Fahad Khalil
Competitive Procurement with Ex Post Moral Hazard

Jan 23, 2019
Marcia Weaver
Funding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilization of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016

Jan 30, 2019
Kangho Suh
Exploring heterogeneity in effectiveness and safety of newer P2Y12 inhibitors vs. clopidogrel in acute coronary syndrome patients

Feb 6, 2019
Jordan Banks
Final Proposal for the Exploration of HealthCoin: A Currency to Address Potential Underfunding by Commercial Payers for Single or Limited Administration Treatments with Long-Term Efficacy

Feb 13, 2019
Jessica Jones-Smith
Did Seattle’s Excise Tax on Sweetened Beverages Get Passed Through to Customers?

Feb 20, 2019
Bianca Frogner
Accessing Physical Therapy: A National Look at the Diagnosing Provider on Downstream Opioid Use

Feb 27, 2019
Kate Lofgren, Harvard University
VOI for Clinicians and Funders: An Accessible Approach to Value Research Aims

Mar 6, 2019
Kritee Gujral
The impact of hospital closures on surrounding hospitals’ patient outcomes

Mar 13, 2019
Chuck Phelps, Au: Health Economics
THE CHOICE INSTITUTE ANNUAL SYMPOSIUM – “Beyond Cost-Effectiveness – Incorporating and Summarizing Multiple Dimensions of Value in Healthcare Technology Assessment”

Apr 3, 2019
Ankur Pandya
Modeling the Cost Effectiveness of Two Big League Pay-for-Performance Policies

Apr 10, 2019
Noah Hammarlund
Racial Treatment Disparities after Machine Learning Surgery-Appropriateness Adjustment

Apr 17, 2019
Allison Portnoy
Health Gains and Financial Protection from Human Papillomavirus (HPV) Vaccination in Ethiopia

Apr 24, 2019
Anirban Basu
A Health Objective Function for Cost-Effectiveness Analysis Without the Baggage of QALYs

May 1, 2019
Edwin Wong
Estimating Unmet VA Primary Care Using Econometric Disequilibrium Models

May 8, 2019
Alex Woersching
Do Price Shopping Opportunities Justify the Hype Around Price Transparency?

May 15, 2019
Kai Yeung
Impact of Specialty Drug Out-Of-Pocket Cap Laws on Patient Financial Burden

May 29, 2019
Aigbokhai Unuigbe
The Lifecycle of Generics

June 5, 2019
Kate Johnson
Understanding disease trajectory to guide precision policy: a case study in COPD

Sept 25, 2019
Kritee Gujral, PhD
Impact of Rural and Urban Hospital Closures on Inpatient Mortality

Oct 16, 2019
Melissa Knox, PhD
Firm Behavior and the Incidence of Sin Taxes: Evidence from Seattle’s Sweetened Beverage Tax

Nov 6, 2019
Kate Rosettie, MPH
Meta-regression analysis of HPV Vaccine Cost-Effectiveness

Nov 13, 2019
Bianca Frogner, PhD
Where to Start? How the First Point of Care Provider Influences Low Back Pain Outcomes and Cost

Dec 4, 2019
Elizabeth Brouwer
Estimating the drug-specific price elasticity of demand for multiple sclerosis (MS) specialty medications in the Kaiser Permanente Washington system accounting for copay assistance

Dec 11, 2019
Lauren Strand
Recreational and medicinal cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2017

January 17, 2018
Jevay Grooms
Race, Gender, and Opioid Treatment Admissions: The Effect of PDMPs on the Most Afflicted

January 24, 2018
Bianca Frogner
Commuting Patterns of Healthcare Workers

January 31, 2018
Carol Levin
Voluntary Male Medical Circumcision (VMMC)  costs and unit costs from the Global Health Cost Consortium

February 7, 2018
Gang Luo
Identifying Future High-Cost Patients for Care Management

February 14, 2018
Liisa Laine
Quality and Competition between Public and Private Firms

February 21, 2018
Shan Liu
Optimizing dynamic decision-making: models and insights for chronic disease care

February 28, 2018
Meng Li
The real option value of life and innovation

March 7, 2018
Mark Bounthavong
Providers’ knowledge, attitude, and satisfaction with Academic Detailing in Opioid Overdose Education and Naloxone Distribution

March 28, 2018
Domenico Depalo, Bank of Italy
Explaining the relation between pills and cholesterol through the marginal patient

April 4, 2018
Yates Coley, KPWHRI
Effectively communicating your research results using statistical graphics

April 11, 2018
Liisa Laine
Market-level effects of a Large-Scale School Choice Reform

April 18, 2018
Amber Sabbatini
Hospital observation stays: implications for costs and quality

April 25, 2018
Ragan Hart
Using Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making

May 2, 2018
Peter Neumann
Special Presentation ( jointly sponsored by HICOR, Fred Hutch)

May 9, 2018
Guido Cataife, IMPAQ
Generalization of the Difference-in-Differences Model for Applied Research

May 16, 2018
Alice Ellyson
The Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law

March 28, 2018
Domenico Depalo, Bank of Italy
Explaining the relation between pills and cholesterol through the marginal patient

April 4, 2018
Yates Coley, KPWHRI
Effectively communicating your research results using statistical graphics

April 11, 2018
Liisa Laine
Market-level effects of a Large-Scale School Choice Reform

April 18, 2018
Amber Sabbatini
Hospital observation stays: implications for costs and quality

April 25, 2018
Ragan Hart
Using Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making

May 2, 2018
Peter Neumann
Special Presentation ( jointly sponsored by HICOR, Fred Hutch)

May 9, 2018
Guido Cataife, IMPAQ
Generalization of the Difference-in-Differences Model for Applied Research

May 16, 2018
Alice Ellyson
The Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law

October 3, 2018
Melissa Knox
Universal health care and chronic disease management: Exploring the role of health care reform in diagnosis and treatment for diabetes-related complications in Mexico

October 10, 2018
Douglas Barthold
The effects of state level pharmacist regulations on generic substitution of subscription drugs

October 17, 2018
Joelle Abramowitz, University of Michigan
Access to Assisted Reproductive Technology and Maternal Mortality

October 24, 2018
Jessica Jones-Smith
Increased economic resources and childhood obesity: A quasi-experimental study

November 7, 2018
Sang-Eun Choi, Korea University
Current pharmaceutical policy and HTA from the Korean National Health Insurance perspective

November 14, 2018
Elizabeth Brouwer
Exploring the shift to value-based formularies in private health insurance 2010-2013 and modeling their potential impact in the future

November 28, 2018
Carrie Bennette, Flatiron Health
Building external control arms for clinical trials using real-world data: opportunities and challenges

December 5, 2018
Anirban Basu
Does current practice of evidence-based medicine breeds disparities?

Amy Cizik, University of Washington
Developing Health State Vignettes for Estimating Health State Utility Values in Soft Tissue Sarcoma: Methods, Lessons, and Implications

Jane Lange, Group Health Research Institute
A Framework for Treatment Decision Making at Prostate Cancer Recurrence

Sungchul Park, University of Washington
Towards assessing individual-level prediction accuracy for healthcare expenditures: comparing alternative estimators for risk adjustment of payments to health plans

Alex Woershing, University of Washington
A Proposal for Evaluating a Campaign to Promote Use of a Price Estimator Web Tool for Clinical Services

Bianca Frogner, University of Washington
Does Medicare Managed Care Affect Diabetic Patient Cost, Use and Quality Associated with Different Medical Labor Inputs

M. Ragan Hart, University of Washington
Projected Cost-Effectiveness of an Array-Based Multi-Gene Pharmacogenetic (PGx) Testing Panel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

Anobel Odisho, University of Washington
Beyond Classical Risk Adjustment: Socioeconomic Status and Hospital Performance in Urologic Oncology

Nicholas Papageorge, Johns Hopkins University
Innovation and Diffusion of Medical Treatment

Joan Teno, University of Washington
Transparency and Accountability for Community Based Programs for High Cost, High Need Patients

Lindsay White, University of Washington
Current costs of Alzheimer’s Care

Ankur Pandya, Harvard University
The Arranged Marriage of Pay-for-Performance and Cost-Effectiveness Analysis in Acute Stroke Care

Theresa Hoeft, University of Washington
Costs when task-sharing depression care between clinic and community partners

Marcia Weaver, University of Washington
Health care utilization: a meta analyses of outpatient visits and inpatient admissions by age, gender for 188 countries from 1990-2015

Solomon Lubinga, University of Washington
Preferences for voluntary medical male circumcision services for HIV prevention: a discrete choice experiment among fisherfolk in central Uganda

Javay Grooms,University of Washington
State prevention interventions and opioid abuse

Seyed Karimi, University of Washington, Tacoma
Pre-Birth Exposure to Ramadan, Height, and the Length of Gestation

Sungchul Park, University of Washington
Theoretical and Empirical Analysis of Medicare Managed Care’s Response to Risk Adjustment

Tricia Rodriguez, University of Washington
Minimizing Barriers to Retention on HIV Antiretroviral Therapy (ART): Results of Haiti’s “Multi-Month Scripting” (MMS) Initiative Extending Prescribing Intervals for ART Patients

Alice Ellyson
Pharmaceutical pricing anticipating entry: the case for insulin

Badri Narayanan G., McKinsey Global Institute and UW
R&D Expenditure, Productivity and Profitability: Evidence from Indian Pharmaceutical Industry

Lisa Laine
Effects of a National Drug Monitoring Intervention on Prescription Drug Abuse

Davene Wright
Financial incentives to promote engagement in family based childhood obesity treatment: development of a discrete choice experiment

Paul Fishman
Measuring Physician Productivity for Efficient Management of Primary Care Panels

Josh Carlson
A Pilot Study Integrating Value of Research Analyses into NCI Clinical Trials Cooperative Group Research Review and Prioritization

Josh Liao
The Value Proposition of Bundled Payment: National and Local Perspectives

Nina Joyce, Brown University
The Impact of Dementia Special Care Units on Quality of Care: An Instrumental Variables Approach

Muxin Zhai, Department of Economics, University of Washington
The impact of maternal exposure to air pollution on infant health.

Peter Zweifel, University of Zurich, Zurich
Willingness-to-Pay for a New Pharmaceutical: Is It Worth the Money? Whose Money?

David Kim, Department of Health Services, University of Washington
New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on evaluating policy alternatives rather than treatment alternatives

Brian Dillon, Evans School of Public Policy and Governance, University of Washington
Long-Term Consequences of Consumption Seasonality

Amy Cizik, PORPP, University of Washington
A Markovian cost Utility Model for Soft Tissue Sarcoma

Carol Levin1 and Suzanne Kerns2, 1Department of Global Health and 2Department of Psychiatry and Behavioral Sciences, University of Washington
Including implementation stages in evaluating the costs of mental health interventions: A case study of scaling up evidence based practices in Washington State

Bianca Frogner, Department of Family Medicine, University of Washington
Does unrestricted direct access to physical therapy impact health spending?

Anirban Basu, PORPP, University of Washington Estimating Price Elasticities from a Value-based Formulary Implementation

Guido Cataife, IMPAQ International, LLC
How much health does a dollar buy? The effect of health care spending on age-adjusted mortality in the US

Kai Yeung, PROPP, University of Washington
Assessing stakeholder experiences and attitudes regarding cures

WEDNESDAY 12:00-1:00 in SOCC 303
Ankur Pandya, Harvard University
Statins, Value and Values

Ben Ely, University of Washington, Department of Health Services
A policy evaluation of the CDC’s campaign: Get Smart about Antibiotics

Sherry Willis, University of Washington, Department of Psychiatry and Behavioral Sciences
Seattle Longitudinal Study: Current Findings and Future Research Possibilities

Erin Vernon, Seattle University, Economics Department
Is Ignorance Bliss? A Systematic Review of Economic Evaluations of Thrombophilia Screening prior to Combined Hormonal Contraceptive Use

Carrie Bennette, University of Washington, PORPP
Evaluating pharmaceutical innovation in the expanding market for oral chemotherapy

Souvik Banerjee,University of Washington, PORPP
Identifying endogenous treatment effects using latent factor models

Carol Levin,University of Washington, Global Health
Improving the Efficiency in HIV and TB: Overview of the Global Health Cost Consortium

John Dickerson, Kaiser Permanente, Center for Health Research
Use of dose-response in clinical trials: challenges and opportunities

Anupam Jena, Havard University
Marathons and Mortality

Melissa Rosen, University of Washington
Changing Medicare Part D Prescription Drug Plans: Estimating the Effects of Plan Switching on under-65 Dual Eligible

Edwin Wong , University of Washington and VA Affairs
Massachusetts Health Reform and Dual Use of VA and non-VA Outpatient Services

Ben Ely,University of Washington
Evaluation of CDC’s Get Smart Program on Appropriate Antibiotics Use

Tiffany Radcliff, Texas A&M University
Price Searching in the Health Insurance Exchange

Melissa Knox, University of Washington
Moral Hazard and Universal Health Care

Scott Emerson, University of Washington
Methods Topic: Clinical trials Bayesian and Frequentist Inference Following Adaptive Trial Design

Susan Shortreed,Group Health Research Institute
Methods Topic: Dynamic Treatments Constructing Optimal Dynamic Antipsychotic Treatment Regimes for Patients with Schizophrenia

Abraham Flaxman, Institute for Health Metrics and Evaluation
Methods Topic: Meta-Regression The Integrative Meta-regression Framework from the Global Burden of Disease (DisMod-MR)

Ruth Etzioni,Fred Hutchinson Cancer Research Center
Methods Topic: Simulation Modeling Simulation modeling as a tool for comparative effectiveness: an overview illustrated by examples from cancer research

Mark Sculpher, University of York, UK
Health Sciences Turner Auditorium, D-209 Is NICE doing more harm than good to population health?

Ali Shojaie, University of Washington
Methods Topic: Machine Learning How reliable are our models in high dimensions?

Carrie Bennette, University of Washington
Methods Topic: Value of Information Minimal Modeling Value of Information Analyses for Prioritization Decisions within a Cancer Clinical Trials Cooperative Group

Holly Janes, Fred Hutchinson Cancer Research Center
Methods Topic: Treatment Effect Heterogeneity (Biomarker Evaluation) An overview of current methodology for designing and analyzing clinical trials evaluating biomarkers for predicting treatment effect

Donald Hedeker,University of Chicago, IL
Methods Topic: Intensive Longitudinal Data Modeling between and within-subject variances using mixed effects location scale models for intensive longitudinal data

Anirban Basu, University of Washington
Methods Topic: Instrumental Variables and Heterogeneity Understanding identification in instrumental variables methods and its application in comparative effectiveness research

Sarah Beth Barnett, University of Washington
Massachusetts health reform: financial and mental health effects

Pierre Thomas Lé, HEC Montreal, Canada
Physician Practice Style and Healthcare Costs: Evidence from Emergency Departments

Bianca Frogner, University of Washington
Health Care Workforce Trends

Kai Yeung,University of Washington
Application of Cost-Effectiveness Logic to US Managed Care Drug Formularies: Long term Outcomes of a Value-based Formulary

Zachary Marcum, University of Washington
Medicare Part D: A Tale of Two Analyses

Tamara Konetzka, University of Chicago, IL
Effects of Malpractice Litigation on Nursing Home Ownership Change and Exit

Benjamin Ely,University of Washington
Acute bronchitis and patterns of antibiotic use

Anirban Basu, University of Washington
2SLS vs 2SRI: Appropriate methods for rare outcomes and/or rare exposures

Souvik Banerjee, University of Washington
An Analysis of the Effect of Psychiatric Disorders on Probation Outcomes and Prison Entry among Probationers in New York State

Ruth Etzioni, University of Washington and Fred Hutch
Limitations of Screening Trials in Developing Cancer Screening Policies

Anirban Basu and Norma Coe, University of Washington
Potential R01s: Where can we collaborate?

Amy Cizik, University of Washington
Variations in Surgeon Treatment Preferences for Soft Tissue Sarcoma: Chronic vs. Temporary Health State Utility Calculations

Norma Coe,University of Washington
Assisted Living Communities’ Impact on Nursing Homes

Bianca Frogner, University of Washington
Low-wage and Low-skilled Health Care Workers

Davene Wright, University of Washington and Seattle Children’s
Hardwired for Hope: Measuring Parental Optimism Bias around Childhood Obesity-Related Outcomes

Carrie Bennett,University of Washington
Evaluating trends in cancer drug prices

Joan Teno, University of Washington
Post acute care and Health Care Reform: Wild, Wild, Wet

Marcia Weaver, Department of Global Health, University of Washington
Integrated infectious disease training and on-site support in Uganda: Design and preliminary results for a cost-effectiveness analysis

Stephane Verguet, Department of Global Health, University of Washington
Universal health coverage & efficient provision of financial risk protection

Lin-Chi Hsu, Department of Economics, University of Washington
The Timing of Welfare Payments and Domestic Violence

Carol Levin, Department of Global Health, University of Washington
A new Global Investment Framework for Women’s and Children’s Health

Nathan Tefft, Department of Health Services, University of Washington
Financial Conflicts of Interest in Medicine

Anupam Jena, Department of Health Care Policy, Harvard Medical School
Mortality among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings

Sarah Taubman, Department of Health Services, University of Washington
Recent results from the Oregon Health Insurance Experiment: Emergency department use and labor market activity

Samuel Henly, Department of Economics, University of Washington
Sex Workers, Job Lock, and the Affordable Care Act

Rosa Avila, Department of Health Services, University of Washington
The Massachusetts Health Reform and Children’s Health: Can We Achieve Health and Health Care Equity among All Children?

Zachary Olson and John Staples, Department of Global Health, University of Washington
Helmet Regulation in Vietnam: An Extended Cost-Effectiveness Analysis

John Dickerson, Department of Health Services, University of Washington
Medication Adherence through Industry-Level Business Cycles: an Application of the Economic Stress Hypothesis

Joshua Roth, Fred Hutchinson Cancer Research Center
Economic Return from the Women’s Health Initiative Estrogen plus Progestin Clinical Trial

Steven Zeliadt, Department of Health Services, University of Washington
Translating lung cancer screening from the trial setting into clinical practice at VA

Justin Robertson, Department of Economics, University of Washington
Are Physicians Learning? Using Person-Centered Treatment Effects to Evaluate Learning Among Medicaid Patients with Schizophrenia

Andrew J. Brunskill, Departments of Epidemiology and Health Services, University of Washington
What is different about smoking in pregnancy : Psychology, physiology and economics

Norma Coe, Department of Health Services, University of Washington
Is There Intra-Family Moral Hazard in Long-Term Care?


Davene R. Wright, Seattle Children’s Research Institute
Improving parental engagement in obesity interventions through risk communication

Edwin S. Wong,VA Puget Sound Health Care System

David D. Kim,Department of Health Services
Long term cost-effectiveness of alcohol-use disorder; PDP review

Justin Robertson,Department of Health Services
Optimal Insurance Contracts with Patients and Payment Contracts with Medical Providers when Threat of Waiving Copayments Exists

Souvik Banerjee, Pharmaceutical Outcomes Research and Policy Program

Steve Zeliadt, University of Washington
Potential Pathways for Containing Costs of Lung Cancer Screening for VHA

Benjamin Hansen, University of Oregon
Medical Marijuana Laws and Teen Drug Use

Joe Dieleman, University of Washington
Measuring the displacement and replacement of development assistance for health

Nathan Tefft, University of Washington
The Dow is Killing Me: Risky Health Behaviors and the Stock Market

Davene Wright, University of Washington
The Cost-Effectiveness of Screening U.S. Adolescents for Eating Disorders

Shamma Alam, University of Washington
How Does Parental Illness Affect Children? Impact of Parental Health Shocks on Child Labor and Education in Tanzania

Norma Coe, University of Washington
Disability and Labor Supply: The Role of Health Insurance

Anirban Basu, University of Washington
Long-Term Health Returns to Quality of Schooling: the Roles of Selection and Heterogeneity

Ruth Etzioni, University of Washington
Measuring Overdiagnosis in Breast and Prostate Cancer Screening: Overcoming Challenges, Avoiding Mistakes

Fahad Khalil, University of Washington
Contracts offered by Bureaucrats

Charles Manski, Northwestern University
Two Problems in Medical Decision Making under Ambiguity

Carol Levin, University of Washington
Using cost analysis to better design global health interventions: Lessons from HPV vaccination in Peru, Uganda, India and Vietnam

Christopher Auld, University of Victoria
Minimum pricing of alcohol: Theory and evidence

Julia Slejko, University of Washington
Using Latent Class Probability Estimation and Residual Inclusion to Address Confounding in Medication Adherence Modeling

Amitabh Chandra, Harvard University
Technology Growth and Expenditure Growth in Health Care

Mark Long, University of Washington
An Altruism Adjusted Measure of the Value of a Statistical Life

Sarah Taubman, University of Washington
The Oregon Health Insurance Experiment: Evidence from the First Two Years

Michael Hanlon, Institute for Health Metrics and Evaluation, University of Washington
Development Assistance for Health: Its allocation and impact on population health

Shamma Alam, Department of Economics, University of Washington
Parental Health Shocks, Child Labor and Educational Outcomes: Evidence from Tanzania

Sarit Weisburd, Departments of Economics, The Hebrew University & University of Washington
Does Police Presence Reduce Car Accidents?

Kathleen Mullen, RAND Corporation
Disability Insurance and Healthcare Reform: Evidence from Massachusetts

Joseph Dieleman, Institute for Health Metrics and Evaluation, University of Washington
A combination of effects: how economic development, development assistance, democratization and government health spending affect under-five mortality

Norma Coe, Department of Health Services, University of Washington
Overcoming Barriers to Life Insurance Coverage: A Behavioral Approach

Arati Dahal, Department of Health Services, University of Washington
The Role of Health on Giving

Damian Walker, Bill and Melinda Gates Foundation (flyer)
The Portfolio Management Pilot: Developing a standard methodology for determining the potential risk and return of products in the Bill & Melinda Gates Foundation Global Health’s investment portfolio

Robert Penfold, Group Health Research Institute
Cumulative Total Charges for Care Among Breast, Colorectal, and Lung Cancer Patients in the Oncology Nurse Navigator Trial

Rachel Nugent, University of Washington
How Does Chronic Disease Control Stack Up Among Economics Nobel Laureates?
Value of Information Experiment Results

Andy Willan, University of Toronto   (*Joint with CHASE WIP – special Wed. session)
Value and Uncertainty in the Pricing New Health Care Interventions (details)

Sean Sullivan, University of Washington
Financial Risk-Sharing Agreements as a Mechanism for Market Access to Health Technology in Low to Middle Income Countries

Joelle Abramowitz, University of Washington
Assisted Reproductive Technology and Women’s Marriage and Birth Timing: Survival and Competing Risks Analyses.

Doug Conrad, University of Washington

Santosh Kumar, Institute for Health Metrics and Evaluation
Geographic constraint to institutional delivery in rural India: An instrumental variable approach

David Meltzer, University of Chicago
Redesign of Care for Patients at High Risk of Hospitalization in a Reforming U.S. Healthcare System: Rationale for a CMMI Innovation Challenge Project